The Latest Evidence in the Diagnosis and Treatment of Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
Release Date: January 7, 2020
Last Reviewed: October 24, 2019
Expiration Date: January 7, 2021
Time to Complete Activity: 1.0 hour
Sebastian H. Unizony, MD
Assistant Professor of Medicine
Harvard Medical School
Co-Director, Vasculitis and Glomerulonephritis Center
Rheumatology, Allergy and Immunology Division
Department of Medicine
Massachusetts General Hospital
Boston, MA
Erica L. Herzog, MD, PhD
Associate Professor
Department of Internal Medicine
Section of Pulmonary, Critical Care, and Sleep Medicine
Director, Interstitial Lung Disease Center of Excellence
Yale School of Medicine
New Haven, CT
J. Charles Jennette, MD
Professor of Pathology and Laboratory Medicine
Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC

This activity is provided by Paradigm Medical Communications, LLC.  
Target Audience
This activity has been designed to address the educational needs of rheumatologists, nephrologists, and pulmonologists. It may also be of benefit to other interested healthcare professionals (HCPs) who treat patients with GPA and MPA.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
• Appropriately diagnose patients with GPA/MPA based on presenting symptoms and diagnostic testing.
• Determine appropriate induction therapy for patients with GPA/MPA.
• Formulate effective, evidence-based maintenance therapy plans for patients with GPA/MPA.
Table of Contents
ANCA-Associated Vasculitides
Diagnosis of GPA and MPA
Induction Therapy for GPA/MPA
Maintenance Therapy for GPA/MPA
Multidisciplinary Management of GPA/MPA
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.  Individuals are responsible for checking with the AANPCP for further guidelines.
This activity is supported by an educational grant from Genentech, Inc.
Instructions for Participation
To receive a CME certificate of participation, you should:
• Follow instructions to register or log in with your professional information and complete the pre-activity assessment
• View the online activity in its entirety.
• Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
Please note: To claim ABIM MOC credit, please make sure you include your date of birth and ABIM number. Please allow 6 to 8 weeks for your points to display on the ABIM website.
Please be aware that de-identified results and educational outcomes of the activity as a whole will be shared with the commercial supporter of this activity as required by the funding letter of agreement.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here:

Technical Support: If you have any technical problems or playback issues email us at
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Sebastian H. Unizony, MD
No financial relationships to disclose.
Erica L. Herzog, MD, PhD
Consulting Fees: Boehringer Ingelheim Pharmaceuticals, Inc
Speakers Bureau: Boehringer Ingelheim Pharmaceuticals, Inc
Grant/Research Support: Boehringer Ingelheim Pharmaceuticals, Inc; Bristol-Myers Squibb Company; sanofi-aventis U.S. LLC
John C. Jennette, MD
Speakers Bureau: ChemoCentryx, Inc; Genentech, Inc
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.
Independent peer reviewers have no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.
Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at
© 2020 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.